Pierre-René Körner

Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors

D. Jäger, R. Agami, H. Glimm, 2022, Oncogene.

Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors

D. Jäger, R. Agami, H. Glimm, 2022, Oncogene.

Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential

R. Elkon, R. Agami, Cheolju Lee, 2022, Molecular cell.

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

P. Carmeliet, H. Horlings, D. Lambrechts, 2022, Nature Communications.

An adverse tumor-protective effect of IDO1 inhibition

R. Agami, O. Krijgsman, D. Peeper, 2023, Cell reports. Medicine.

Anti-tumour immunity induces aberrant peptide presentation in melanoma

Ronen Levy, Remco Nagel, R. Agami, 2020, Nature.

2022-RA-953-ESGO Serine metabolism remodeling after platinum-based chemotherapy is a new vulnerability in resistant ovarian cancer patients

H. Horlings, R. Agami, F. Amant, 2022, Ovarian cancer.